Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Atwell

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Molecular Immunology|December 1, 1996
Design and expression of a stable bispecific scFv dimer with affinity for both glycophorin and N9 neuraminidaseJ L Atwell, L A Pearce, M Lah, et al.
Veterinary Microbiology|July 1, 1995
The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK)A W Lepper, J L Atwell, P R Lehrbach, et al.
Journal of Medicinal Chemistry|October 1, 1983
Biological effects of modified colchicines. 2. Evaluation of catecholic colchicines, colchifolines, colchicide, and novel N-acyl- and N-aroyldeacetylcolchicinesA Brossi, P N Sharma, L Atwell, et al.
Protein Engineering|August 6, 1999
scFv multimers of the anti-neuraminidase antibody NC10: length of the linker between VH and VL domains dictates precisely the transition between diabodies and triabodiesJ L Atwell, K A Breheney, L J Lawrence, et al.
Toxicology and Applied Pharmacology|April 10, 2013
Differential modulation of dibenzo[def,p]chrysene transplacental carcinogenesis: maternal diets rich in indole-3-carbinol versus sulforaphaneLyndsey E Shorey, Erin P Madeen, Lauren L Atwell, et al.
Journal of Medicinal Chemistry|March 1, 1981
Biological effects of modified colchicines. Improved preparation of 2-demethylcolchicine, 3-demethylcolchicine, and (+)-colchicine and reassignment of the position of the double bond in dehydro-7-deacetamidocolchicinesM Rösner, H G Capraro, A E Jacobson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 30, 2015
Sulforaphane Bioavailability and Chemopreventive Activity in Women Scheduled for Breast BiopsyLauren L Atwell, Zhenzhen Zhang, Motomi Mori, et al.
Veterinary Microbiology|July 1, 1993
A Moraxella bovis pili vaccine produced by recombinant DNA technology for the prevention of infectious bovine keratoconjunctivitisA W Lepper, T C Elleman, P A Hoyne, et al.
Pediatrics|June 15, 2021
Trends and Factors Related to Blunt Use in Middle and High School Students, 2010-2020Mohammad Ebrahimi Kalan, Rime Jebai, Zoran Bursac, et al.
Protein Engineering|April 1, 1997
Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimerA A Kortt, M Lah, G W Oddie, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Molecular Immunology|December 1, 1996
Design and expression of a stable bispecific scFv dimer with affinity for both glycophorin and N9 neuraminidaseJ L Atwell, L A Pearce, M Lah, et al.
Veterinary Microbiology|July 1, 1995
The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK)A W Lepper, J L Atwell, P R Lehrbach, et al.
Journal of Medicinal Chemistry|October 1, 1983
Biological effects of modified colchicines. 2. Evaluation of catecholic colchicines, colchifolines, colchicide, and novel N-acyl- and N-aroyldeacetylcolchicinesA Brossi, P N Sharma, L Atwell, et al.
Protein Engineering|August 6, 1999
scFv multimers of the anti-neuraminidase antibody NC10: length of the linker between VH and VL domains dictates precisely the transition between diabodies and triabodiesJ L Atwell, K A Breheney, L J Lawrence, et al.
Toxicology and Applied Pharmacology|April 10, 2013
Differential modulation of dibenzo[def,p]chrysene transplacental carcinogenesis: maternal diets rich in indole-3-carbinol versus sulforaphaneLyndsey E Shorey, Erin P Madeen, Lauren L Atwell, et al.
Journal of Medicinal Chemistry|March 1, 1981
Biological effects of modified colchicines. Improved preparation of 2-demethylcolchicine, 3-demethylcolchicine, and (+)-colchicine and reassignment of the position of the double bond in dehydro-7-deacetamidocolchicinesM Rösner, H G Capraro, A E Jacobson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 30, 2015
Sulforaphane Bioavailability and Chemopreventive Activity in Women Scheduled for Breast BiopsyLauren L Atwell, Zhenzhen Zhang, Motomi Mori, et al.
Veterinary Microbiology|July 1, 1993
A Moraxella bovis pili vaccine produced by recombinant DNA technology for the prevention of infectious bovine keratoconjunctivitisA W Lepper, T C Elleman, P A Hoyne, et al.
Pediatrics|June 15, 2021
Trends and Factors Related to Blunt Use in Middle and High School Students, 2010-2020Mohammad Ebrahimi Kalan, Rime Jebai, Zoran Bursac, et al.
Protein Engineering|April 1, 1997
Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimerA A Kortt, M Lah, G W Oddie, et al.
Pageof 3